EMJ Allergy & Immunology 7.1 2022

We are delighted to welcome you to the latest issue of EMJ Allergy & Immunology. Sharing key updates in the field in the form of reviews and research articles, our latest issue features insights into paediatric allergen–specific immunotherapy studies, mast–cell mediated diseases, and the role of Janus kinase inhibitors in rheumatoid arthritis, as well as spotlighting interesting dermatitis case reports. Also included, is a comprehensive review of the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2022, with late breaking abstract reviews featuring novel research.